You need JavaScript to view this

Measurement of Placental Blood Flow with {sup 133}Xe in Normal and Pathological Human Pregnancy; Mesure du Debit Placentaire dans les Grossesses Normales et Pathologiques

Abstract

Most authors agree that changes in placental circulation play an important part in the genesis of chronic foetal disorders. However, until recently there was no technique by which a quantitative evaluation of placental haemodynamics could be obtained. Our method of measuring placental blood flow represents one application of the use of radioisotopes for measurements of local blood flows. We use {sup 133}Xe in solution in physiological serum. This radioactive gas has the advantage of being inert and instantly diffusible. After radiographic or ultrasonic localization of the placenta, 50 {mu}Ci of xenon are injected into it transabdominally. A scintillation detector is used to take the {sup 133}Xe clearance curve, which is recorded simultaneously on a linear writer and transmitted to a computer. We have made 111 measurements of placental blood flow - 45 in normal pregnancy, 59 in pathological pregnancy and 7 after perfusion of medication. The measurements made it possible to obtain, for the first time, a quantitative evaluation of placental blood flow in women. The value found for normal pregnancies between the thirty-second and the forty-first weeks was 145 ml/100 g per min. The measurements carried out in pathologically pregnant patients (with arterial hypertension, dysgravidity, urinary infection, diabetes, prolonged  More>>
Authors:
Pontonnier, G.; Delmas, H.; Farre, J.; Favretto, R. [1] 
  1. Clinique Obstetricale, Hopital de la Grave, Toulouse (France)
Publication Date:
Feb 15, 1971
Product Type:
Conference
Report Number:
IAEA-SM-136/86
Resource Relation:
Conference: Symposium on Dynamics Studies with Radioisotopes in Clinical Medicine and Research, Rotterdam (Netherlands), 31 Aug - 4 Sep 1970; Other Information: 4 refs.; Related Information: In: Dynamic Studies with Radioisotopes in Medicine. Proceedings of the Symposium on Dynamics Studies with Radioisotopes in Clinical Medicine and Research| 924 p.
Subject:
62 RADIOLOGY AND NUCLEAR MEDICINE; BLOOD FLOW; CHILDREN; DRUGS; EVALUATION; HYPERTENSION; MEDICAL SURVEILLANCE; PARTURITION; PATIENTS; PLACENTA; PREGNANCY; SCINTILLATION COUNTERS; WOMEN; XENON; XENON 133
OSTI ID:
22127362
Research Organizations:
International Atomic Energy Agency, Vienna (Austria)
Country of Origin:
IAEA
Language:
French
Other Identifying Numbers:
Other: ISSN 0074-1884; TRN: XA13M2775082441
Submitting Site:
INIS
Size:
page(s) 611-620
Announcement Date:
Sep 12, 2013

Citation Formats

Pontonnier, G., Delmas, H., Farre, J., and Favretto, R. Measurement of Placental Blood Flow with {sup 133}Xe in Normal and Pathological Human Pregnancy; Mesure du Debit Placentaire dans les Grossesses Normales et Pathologiques. IAEA: N. p., 1971. Web.
Pontonnier, G., Delmas, H., Farre, J., & Favretto, R. Measurement of Placental Blood Flow with {sup 133}Xe in Normal and Pathological Human Pregnancy; Mesure du Debit Placentaire dans les Grossesses Normales et Pathologiques. IAEA.
Pontonnier, G., Delmas, H., Farre, J., and Favretto, R. 1971. "Measurement of Placental Blood Flow with {sup 133}Xe in Normal and Pathological Human Pregnancy; Mesure du Debit Placentaire dans les Grossesses Normales et Pathologiques." IAEA.
@misc{etde_22127362,
title = {Measurement of Placental Blood Flow with {sup 133}Xe in Normal and Pathological Human Pregnancy; Mesure du Debit Placentaire dans les Grossesses Normales et Pathologiques}
author = {Pontonnier, G., Delmas, H., Farre, J., and Favretto, R.}
abstractNote = {Most authors agree that changes in placental circulation play an important part in the genesis of chronic foetal disorders. However, until recently there was no technique by which a quantitative evaluation of placental haemodynamics could be obtained. Our method of measuring placental blood flow represents one application of the use of radioisotopes for measurements of local blood flows. We use {sup 133}Xe in solution in physiological serum. This radioactive gas has the advantage of being inert and instantly diffusible. After radiographic or ultrasonic localization of the placenta, 50 {mu}Ci of xenon are injected into it transabdominally. A scintillation detector is used to take the {sup 133}Xe clearance curve, which is recorded simultaneously on a linear writer and transmitted to a computer. We have made 111 measurements of placental blood flow - 45 in normal pregnancy, 59 in pathological pregnancy and 7 after perfusion of medication. The measurements made it possible to obtain, for the first time, a quantitative evaluation of placental blood flow in women. The value found for normal pregnancies between the thirty-second and the forty-first weeks was 145 ml/100 g per min. The measurements carried out in pathologically pregnant patients (with arterial hypertension, dysgravidity, urinary infection, diabetes, prolonged pregnancy) showed that such pregnancies are accompanied by a statistically significant diminution of placental blood flow, and that the magnitude of this diminution has a bearing on the clinical condition and the state of the child at birth. This method of measurement, which is easily reproducible in the same patient, is accordingly of interest from two points of view. As far as theoretical studies are concerned, it has made possible a quantitative evaluation of placental blood flow and has supplied proof that the maternal disorders which give rise to chronic foetal disorders are usually accompanied by a diminution in placental blood flow. From the practical standpoint, it provides one more element for the surveillance of pregnancies involving high foetal risk and makes it possible to study the action of drugs administered to the mother on placental blood flow. (author) [French] La plupart des auteurs s'accordent a reconnaitre l'importance des alterations de la circulation placentaire dans la genese de la souffrance foetale chronique. Or il n'existait pas jusqu'ici de technique qui permette une evaluation quantitative de l'hemodynamique placentaire. Les auteurs presentent une methode de mesure du debit placentaire qui est une application des radioisotopes a la mesure des debits locaux. Ils utilisent le xenon-133 en solution dans du serum physiologique; ce gaz radioactif presente l'avantage d'etre inerte et instantanement diffusible. Apres localisation radiographique ou ultrasonique du placenta, ils injectent par voie trans-abdominale 50 {mu}Ci de xenon dans le placenta. L'enregistrement de la courbe de clearance du xenon-133 est effectue au moyen d'un detecteur a scintillation. La courbe obtenue est en meme temps enregistree sur un inscripteur lineaire et transmise a un calculateur automatique. Les auteurs ont ainsi realise 111 mesures de debit placentaire: 45 dans des grossesses normales, 59 dans des grossesses pathologiques et 7 apres perfusion medicamenteuse. Les mesures effectuees ont permis pour la premiere fois de chiffrer la valeur du debit placentaire chez la femme. Pour les grossesses normales, entre la 32{sup e} et la 41{sup e} semaine, il est de 145 ml/100 g/min. Les mesures effectuees au cours de grossesses pathologiques (hypertension arterielle, dysgravidie, infection urinaire, diabete, grossesse prolongee) ont montre que celles-ci s'accompagnent d'une diminution du debit placentaire statistiquement significative. L'importance de cette diminution est en rapport avec la clinique et l'etat de l'enfant a la naissance. Cette methode de mesure, facilement reproductible chez la meme femme, presente donc un double interet. Sur le plan theorique, elle a permis de chiffrer le debit placentaire et de prouver que les affections maternelles generatrices de souffrance foetale chronique s'accompagnaient habituellement d'une diminution de ce debit. Sur le plan pratique, elle fournit un element de plus pour la surveillance des grossesses a haut risque foetal et permet d'etudier l'action sur le debit placentaire de drogues administrees a la mere. (author)}
place = {IAEA}
year = {1971}
month = {Feb}
}